cabozantinib (XL-184),a C-met/VEGF2 Inhibitors.
Posted: Fri Feb 24, 2012 10:12 am
cabozantinib (XL-184),a C-met/VEGF2 Inhibitors. have a high efficiency for bone metastases
http://www.exelixis.com/cabozantinib/bo ... s/MET-VEGF
http://www.exelixis.com/sites/default/f ... A90%29.pdf
http://www.exelixis.com/sites/default/f ... 84-RDT.pdf
http://www.exelixis.com/cabozantinib/bo ... s/MET-VEGF
http://www.exelixis.com/sites/default/f ... A90%29.pdf
http://www.exelixis.com/sites/default/f ... 84-RDT.pdf